Charles Schwab Investment Management Inc Axogen, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 335,105 shares of AXGN stock, worth $4.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
335,105
Previous 346,953
3.41%
Holding current value
$4.62 Million
Previous $2.8 Million
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AXGN
# of Institutions
129Shares Held
35.8MCall Options Held
79.1KPut Options Held
500-
Arrow Mark Colorado Holdings LLC Denver, CO5.12MShares$70.6 Million0.49% of portfolio
-
First Light Asset Management, LLC Edina, MN3.34MShares$46.1 Million2.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.31MShares$45.6 Million2.42% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$44.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.52MShares$34.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $583M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...